跳至主要内容
临床试验/NCT07725328
NCT07725328Enrolling By Invitation不适用

Pragmatic Randomized Trial Using Mobile Health (mHealth) Technology to Change Cancer Screening Behavior and Promote Healthier Lifestyle

National University Hospital, Singapore1 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2026年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
2,000
试验地点
1
主要终点
Comparison of Screen-Adherent Participants Between Arm 1 and Arm 2

研究概览

简要总结

Cancer is the leading cause of death in Singapore, but many people who are eligible for breast, cervical, and colorectal cancer screening do not get screened on time. Many adults also have chronic health conditions such as high blood pressure, diabetes, high cholesterol, and obesity, which can often be reduced through healthier lifestyle habits. Although reminders for screening are available, they may not be enough to encourage long-term healthy behaviours.

This study will evaluate whether regular health messages delivered through a mobile health (mHealth) platform can help improve cancer screening participation and promote healthier lifestyles among Singaporean women aged 50-69 years. Participants will be randomly assigned to one of two groups. The control group will receive standard cancer screening reminders every six months. The intervention group will receive monthly evidence-based health messages, including information on cancer screening, healthy eating, physical activity, and other healthy lifestyle behaviours, delivered through the NUHS App (or a similar mobile platform) or SMS.

The study will compare whether more frequent and engaging health messages lead to higher participation in recommended cancer screening, greater engagement with the digital platform, and healthier lifestyle behaviours compared with standard reminders. The findings may help identify an effective and scalable digital approach to support cancer prevention and healthy ageing across Singapore.

详细描述

Cancer remains the leading cause of death in Singapore despite the availability of national screening programmes for breast, cervical, and colorectal cancers. Participation in recommended cancer screening remains below desired levels, while chronic diseases associated with unhealthy lifestyle behaviours continue to increase. Existing approaches to promoting preventive health often rely on infrequent reminders and may be insufficient to support sustained behavioural change.

Singapore's widespread use of smartphones and digital health platforms provides an opportunity to deliver scalable mobile health (mHealth) interventions. This pragmatic randomized trial will evaluate whether regular delivery of evidence-based health messages through the NUHS App (or a similar mobile platform) or SMS can improve participation in recommended cancer screening and promote healthier lifestyle behaviours among Singaporean women aged 50-69 years.

Participants will receive either standard screening reminders or a more intensive programme of health messages covering cancer screening, healthy diet, physical activity, weight management, and other preventive health topics. The study will evaluate whether a sustained digital engagement strategy is more effective than standard reminders in encouraging long-term health behaviour change.

Because the intervention is delivered using existing healthcare digital infrastructure, the findings will inform whether this approach can be implemented at scale to improve cancer prevention and support healthy ageing in Singapore.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Screening
盲法
None

入排标准

年龄范围
50 Years 至 69 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • If using app for message delivery: Registered NUHS App users or HealthHub App users OR if using SMS for message delivery: Participants must have a mobile number recorded in electronic medical records (EPIC).
  • Singapore citizen
  • Aged 50-69 years
  • With or without prior diagnosis of cancer

排除标准

  • Participants unable to provide informed consent and take surveys, such as those with cognitive impairments or severe mental health conditions.
  • Participants with terminal illness or serious comorbidities that preclude them from participating in preventive health programs.
  • Pregnant women: Given the target age group (50-69 years), the prevalence of pregnancy is expected to be extremely low.

结局指标

主要结局

Comparison of Screen-Adherent Participants Between Arm 1 and Arm 2

时间窗: 24 months post-intervention

Proportion of screen-adherent participants (in %) in Arm-2 versus Arm-1 at 24 months. Non-adherence at baseline is defined as not being fully adherent to screening guidelines for all three cancers (with cervical cancer screening excluded for those not sexually active). Adherence following the intervention is defined as showing at least one improvement in adherence (e.g., previously adherent to only cervical cancer screening, with subsequent adherence to colorectal cancer screening).

次要结局

  • Proportion of participants with BMI in the healthy range(24 months post-intervention)
  • Proportion of participants achieving a daily goal of 10,000 steps(24 months post-intervention)
  • Proportion of participants with recommended moderate-intensity aerobic activity(24 months post-intervention)
  • Proportion of participants eating recommended servings of fruits/vegetables daily at 24 months(24 months post-intervention)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Enrolling By Invitation
不适用
Trial to Evaluate the Impact of Various Pragmatic Interventions to Increase Mammography Uptake Among Defaulted Repeat Screeners in SingaporeMammogram UptakeBreast NeoplasmEarly Detection of CancerEarly Breast Cancer DetectionMammography ScreeningBreast Cancer
NCT07651345National University Hospital, Singapore12,750
Enrolling By Invitation
不适用
Trial to Evaluate the Impact of Various Behavioural Interventions to Increase Mammography Uptake Among Singaporean Women
NCT07283107National University Hospital, Singapore8,910
尚未招募
不适用
Study to Assess the Efficacy and Validation of a QPCR Test for Auxiliary Diagnosis of High Prevalence Cancers Using Whole Blood mRNAMalignant neoplasm of esophagus, (2) ICD-10 Condition: C50||Malignant neoplasm of breast, (3) ICD-10 Condition: C34||Malignant neoplasm of bronchus andlung, (4) ICD-10 Condition: C18||Malignant neoplasm of colon, (5) ICD-10 Condition: C25||Malignant neoplasm of pancreas, (6) ICD-10 Condition: C00-C14||Malignant neoplasms of lip, oral cavity and pharynx, (7) ICD-10 Condition: C53||Malignant neoplasm of cervix uteri, (8) ICD-10 Condition: C22||Malignant neoplasm of liver and intrahepatic bile ducts, (9) ICD-10 Condition: C16||Malignant neoplasm of stomach,
CTRI/2026/04/107355Biomavericks India Pvt ltd50
尚未招募
不适用
Effectiveness of AnshCare App on maternal and neonatal outcomes among mothers and their newborns.
CTRI/2025/08/093595Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala100
尚未招募
不适用
Effectiveness of an AI-Enabled Mobile Intervention on Lifestyle Behaviors and Maternal-Infant Health
NCT07582068Fangbiao Tao400